Fortem Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,500
| Closed | -$170K | – | 179 |
|
|
2021
Q3 | $170K | Buy |
17,500
+2,000
| +13% | +$19.4K | 0.09% | 168 |
|
|
2021
Q2 | $153K | Sell |
15,500
-10,000
| -39% | -$98.7K | 0.08% | 162 |
|
|
2021
Q1 | $294K | Sell |
25,500
-2,500
| -9% | -$28.8K | 0.17% | 138 |
|
|
2020
Q4 | $270K | Sell |
28,000
-1,000
| -3% | -$9.64K | 0.16% | 127 |
|
|
2020
Q3 | $261K | Buy |
29,000
+2,500
| +9% | +$22.5K | 0.19% | 122 |
|
|
2020
Q2 | $327K | Hold |
26,500
| – | – | 0.25% | 93 |
|
|
2020
Q1 | $238K | Buy |
26,500
+4,000
| +18% | +$35.9K | 0.22% | 91 |
|
|
2019
Q4 | $221K | Buy |
22,500
+500
| +2% | +$4.91K | 0.16% | 105 |
|
|
2019
Q3 | $151K | Sell |
22,000
-22,200
| -50% | -$152K | 0.13% | 105 |
|
|
2019
Q2 | $408K | Buy |
+44,200
| New | +$408K | 0.41% | 60 |
|
|
2019
Q1 | – | Sell |
-15,900
| Closed | -$245K | – | 147 |
|
|
2018
Q4 | $245K | Buy |
+15,900
| New | +$245K | 0.3% | 75 |
|